Feb 2 | News
KARACHI, Pakistan (AP) — Pakistani authorities have closed a drug factory alleged to have made faulty heart medicine that killed over 100 patients.
|
Jan 19 | News
HANOI, Vietnam (AP) — Vietnam has confirmed its first human death from bird flu in nearly two years, a day after neighboring Cambodia also logged its first fatality this year as new cases of the H5N1 virus are reported in Asia and the Middle East.
|
Jan 18 | News
Novartis said today that it received Chinese regulatory approval for its eye drug Lucentis, and it is launching the diabetes treatment Galvus in China.
|
Jan 16 | News
Indian doctors have reported the country's first cases of "totally drug-resistant tuberculosis," a long-feared and virtually untreatable form of the killer lung disease.
|
Jan 12 | News
NEW DELHI (AP) — India will celebrate a full year since its last reported case of polio on Friday, a major victory in a global eradication effort that appeared to be stalled just a few years ago.
|
Jan 10 | News
The global fight against the tuberculosis epidemic receives a boost today as Aeras and the China National Biotec Group (CNBG) announce that they have reached final agreement to jointly develop new tuberculosis (TB) vaccines.
|
Jan 9 | News
Pfizer Inc., has entered an agreement with drug developer SFJ Pharma Ltd. II to conduct a late-stage trial in Asia of Pfizer's potential kidney cancer treatment axitinib.
|
Jan 3 | News
BEIJING (AP) — The strain of H5H1 bird flu that killed a Chinese man cannot spread among people, a health agency said Monday, appealing for calm after the country's first reported case of the disease in humans in 18 months.
|
Dec 14 2011 | News
Bristol-Myers Squibb Company and Simcere Pharmaceutical Group, a leading pharmaceutical company in China, today announced that the companies have expanded the strategic partnership formed last year to include a second collaboration in a different therapeutic area.
|
Dec 13 2011 | News
BEIJING--(BUSINESS WIRE)--Dec. 13, 2011-- Further deepening its commitment to China, Quintiles today announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.
|